Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 2.1T | 3.1T | 1.9T | 3.5T |
Cost of revenue | 1.0T | 1.6T | 855.0B | 1.7T |
Gross profit | 1.1T | 1.5T | 1.0T | 1.9T |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 201.8B | 265.7B | 162.0B | 177.4B |
Other operating expenses | 133.3M | 71.0B | 52.0B | 10.2B |
Operating income | 629.3B | 949.3B | 551.3B | 1.5T |
Non operating interest income | ||||
Income | 41.7B | 42.9B | 38.0B | 50.0B |
Expense | 265.2B | 267.6B | 247.8B | 259.1B |
Other income expense | — | — | — | — |
Pretax income | 316.8B | 606.6B | 240.8B | 570.7B |
Tax provision | 759.1M | 18.1B | -642.8M | 4.1B |
Net income | 316.0B | 588.5B | 241.4B | 566.7B |
Basic EPS | 14.4 | — | — | — |
Diluted EPS | 14.4 | — | — | — |
Basic average shares | 16.5B | — | — | — |
Diluted average shares | 16.5B | — | — | — |
EBITDA | 603.3B | 923.2B | 508.3B | 850.1B |
Net income from continuing op. | — | — | — | — |
Minority interests | -77.8B | -148.8B | -61.4B | -254.4B |
Preferred stock dividends | 0 | 0 | 0 | 0 |